BioMedSA’s Board of Directors approved 4 new memberships in March and April 2025: ClinLab Staffing, Flintco, Page, and Taurus Vascular
ClinLab Staffing is a recruitment firm focused exclusively on the life sciences sector, supporting both academic and industrial organizations. Since 2002, they have emphasized a results-driven approach, connecting clients with skilled professionals who can contribute immediately to scientific and operational goals. Their expertise spans a wide range of disciplines, including manufacturing (upstream and downstream), research and development, molecular biology, microbiology, quality control, and more. ClinLab is known for its transparent, client-focused service and commitment to aligning talent with specific project needs.
Founded in 1908, Flintco operates eight full-service offices across the United States. The company is registered or licensed in 34 states and provides a comprehensive range of construction services, including preconstruction, construction management, design-build, general contracting, and project and program management. Flintco also maintains self-perform capabilities in concrete, steel erection, excavation, underground infrastructure, and piping. The company is debt-free and maintains a strong balance sheet with significant bonding capacity. Flintco’s safety program, Flintco 4 LIFE (Live Incident Free Everyday), is a behavioral-based approach that has contributed to improved outcomes for clients and trade partners. Additionally, the company has implemented Lean2.0, a tailored approach to Lean construction practices aimed at enhancing efficiency and delivering value across projects.
Page is a multidisciplinary architecture and engineering firm known for its imaginative and collaborative approach. The team combines creative vision with technical expertise to develop spaces that are both forward-thinking and grounded in practical execution. They emphasize the integration of form and function, balancing innovation with real-world application. With a focus on enhancing the environments where people live, work, and learn, Page is committed to thoughtful, human-centered design. Their professionals work across disciplines to envision comprehensive solutions and bring them to life with clarity and precision.
Taurus Vascular is a medical device company focused on advancing the treatment of abdominal aortic aneurysms (AAAs). The company has developed a novel aortocaval shunt technology that aims to improve outcomes beyond what is currently achievable with standard endovascular aneurysm repair (EVAR). By creating a controlled connection between the aorta and the vena cava, this approach enables pressure relief within the aneurysm sac. This mechanism is intended to promote aneurysm shrinkage and reduce the likelihood of post-procedural complications. Taurus Vascular’s work represents a significant step toward addressing persistent challenges in AAA management through a new therapeutic pathway.
